<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
    xmlns:admin="http://webns.net/mvcb/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:content="http://purl.org/rss/1.0/modules/content/">

    <channel>
    
    <title>News</title>
    <link>http://www.cancertechnology.com/</link>
    <description></description>
    <dc:language>en</dc:language>
    <dc:creator>saustin@cancertechnology.com</dc:creator>
    <dc:rights>Copyright 2012</dc:rights>
    <dc:date>2012-03-29T05:56:27+00:00</dc:date>
    <admin:generatorAgent rdf:resource="http://expressionengine.com/" />
    

    <item>
      <title>CRT and The EIF unveil innovative £50M cancer fund to bridge &#8216;development gap&#8217; in UK</title>
      <link>http://www.cancertechnology.com/site/crt_eif_pioneer_fund/</link>
      <guid>http://www.cancertechnology.com/site/crt_eif_pioneer_fund/#When:05:56:27Z</guid>
      <description>CRT and the European Investment Fund (EIF) have joined together to create a £50M investment fund to bridge the funding gap in the UK between cancer drug discovery and early development.</description>
      <dc:subject>Press Releases</dc:subject>
      <dc:date>2012-03-29T05:56:27+00:00</dc:date>
    </item>

    <item>
      <title>CRT unveils ‘screen test’ for potential drugs to treat oestrogen positive breast cancer</title>
      <link>http://www.cancertechnology.com/site/crt_FOXA1/</link>
      <guid>http://www.cancertechnology.com/site/crt_FOXA1/#When:11:46:23Z</guid>
      <description>CANCER RESEARCH UK CRT and Cancer Research UK have developed a unique test to discover molecules that could lead to potential new treatments for oestrogen receptor (ER)&#45;positive* breast cancer.</description>
      <dc:subject>Press Releases</dc:subject>
      <dc:date>2012-03-05T11:46:23+00:00</dc:date>
    </item>

    <item>
      <title>Curis Announces FDA Approval of Erivedge (vismodegib) Capsule as First Treatment for Advanced BCC</title>
      <link>http://www.cancertechnology.com/site/vismodegib/</link>
      <guid>http://www.cancertechnology.com/site/vismodegib/#When:14:13:01Z</guid>
      <description></description>
      <dc:subject>CRT in the News</dc:subject>
      <dc:date>2012-01-30T14:13:01+00:00</dc:date>
    </item>

    <item>
      <title>CRT spins out company to develop cancer surgery  machine to melt tumours</title>
      <link>http://www.cancertechnology.com/site/acublate/</link>
      <guid>http://www.cancertechnology.com/site/acublate/#When:06:30:35Z</guid>
      <description>CRT has today launched Acublate Limited, a spin&#45;out company which will develop a next&#45;generation High Intensity Focused Ultrasound (HIFU) surgery device to treat a range of solid tumour types.</description>
      <dc:subject>Press Releases</dc:subject>
      <dc:date>2012-01-26T06:30:35+00:00</dc:date>
    </item>

    <item>
      <title>Call for Reagents</title>
      <link>http://www.cancertechnology.com/site/reagents/</link>
      <guid>http://www.cancertechnology.com/site/reagents/#When:08:52:08Z</guid>
      <description></description>
      <dc:subject>CRT in the News</dc:subject>
      <dc:date>2011-12-15T08:52:08+00:00</dc:date>
    </item>

    <item>
      <title>Stephen Friend visits CRT to discuss Arch2POCM</title>
      <link>http://www.cancertechnology.com/site/peter_friend/</link>
      <guid>http://www.cancertechnology.com/site/peter_friend/#When:04:19:48Z</guid>
      <description></description>
      <dc:subject>CRT in the News</dc:subject>
      <dc:date>2011-12-15T04:19:48+00:00</dc:date>
    </item>

    <item>
      <title>FEATURE: CCR4 &#45; from target discovery to a license and sponsored collaboration with Affitech</title>
      <link>http://www.cancertechnology.com/site/ccr4/</link>
      <guid>http://www.cancertechnology.com/site/ccr4/#When:04:15:59Z</guid>
      <description></description>
      <dc:subject>CRT in the News</dc:subject>
      <dc:date>2011-12-15T04:15:59+00:00</dc:date>
    </item>

    <item>
      <title>FEATURE: Successful Discovery Committee grant application shows promise for novel drug combinations</title>
      <link>http://www.cancertechnology.com/site/successful_DC/</link>
      <guid>http://www.cancertechnology.com/site/successful_DC/#When:04:14:41Z</guid>
      <description></description>
      <dc:subject>CRT in the News</dc:subject>
      <dc:date>2011-12-15T04:14:41+00:00</dc:date>
    </item>

    <item>
      <title>FEATURE: CRT reflects on a successful NCRI conference</title>
      <link>http://www.cancertechnology.com/site/crt_ncri_conference/</link>
      <guid>http://www.cancertechnology.com/site/crt_ncri_conference/#When:04:14:35Z</guid>
      <description></description>
      <dc:subject>CRT in the News</dc:subject>
      <dc:date>2011-12-15T04:14:35+00:00</dc:date>
    </item>

    <item>
      <title>CRT appoints new Chairman to its Board of Directors</title>
      <link>http://www.cancertechnology.com/site/crt_appoints_new_chairman_to_its_board_of_directors/</link>
      <guid>http://www.cancertechnology.com/site/crt_appoints_new_chairman_to_its_board_of_directors/#When:07:37:42Z</guid>
      <description>Cancer Research Technology today announced the appointment of Peter Chambré as its new chairman.</description>
      <dc:subject>Press Releases</dc:subject>
      <dc:date>2011-10-13T07:37:42+00:00</dc:date>
    </item>

    
    </channel>
</rss>
